Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Why Shares of Harmony Bioscience Are Falling on Friday | fool.com • |
Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today? | investorplace.com • |
Zynerba Pharma stock rockets on premium priced Harmony deal | proactiveinvestors.com • |
Harmony Biosciences to buy Zynerba Pharmaceuticals for up to $200 million | marketwatch.com • |
Zynerba (ZYNE) Upgraded to Buy: What Does It Mean for the Stock? | zacks.com • |
Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference | globenewswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-11-13 | 2023-09 | -0.2 | N/A | N/A | N/A |
2023-08-14 | 2023-06 | -0.2 | N/A | N/A | N/A |
2023-05-15 | 2023-03 | -0.2 | N/A | N/A | N/A |
2023-03-28 | 2022-12 | -0.24 | N/A | N/A | N/A |
2022-11-14 | 2022-09 | -0.21 | N/A | N/A | N/A |
2022-08-10 | 2022-06 | -0.21 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-15 | Canaccord Genuity | Downgrade | Buy | Hold |
2023-08-14 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2022-06-22 | Canaccord Genuity | Upgrade | Buy | |
2020-06-30 | Needham | Downgrade | Buy | Hold |
2020-05-27 | Cantor Fitzgerald | Upgrade | Overweight | |
2019-10-20 | Needham | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-10-09 | ANIDO ARMANDO | Chief Executive Officer | 0.00 | Stock Award(Grant) |
2023-06-13 | COOPER WARREN D | Director | 75.78K | Sale |
2023-06-13 | FEDERICI WILLIAM J | Director | 75.78K | Sale |
2023-10-09 | FICKENSCHER JAMES E | Chief Financial Officer | 0.00 | Stock Award(Grant) |
2023-10-09 | JONES KENNETH T | Chief Financial Officer | 0.00 | Stock Award(Grant) |
2023-06-13 | KISNER DANIEL L | Director | 75.78K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 2.18M | 710.55K | 4.04% |
2023-06-29 | Blackrock Inc. | 740.52K | 241.41K | 1.37% |
2023-03-30 | ETF Managers Group, LLC | 723.15K | 310.95K | 1.34% |
2023-06-29 | Renaissance Technologies, LLC | 689.71K | 224.85K | 1.28% |
2023-06-29 | Geode Capital Management, LLC | 387.35K | 126.27K | 0.72% |
2023-06-29 | Penserra Capital Management LLC | 220.86K | 72.00K | 0.41% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.52M | 496.11K | 2.82% |
2023-06-29 | Vanguard Extended Market Index Fund | 604.16K | 196.95K | 1.12% |
2023-05-30 | Fidelity Extended Market Index Fund | 238.97K | 79.82K | 0.44% |
2023-07-30 | Amplify Seymour Cannabis ETF | 220.86K | 80.61K | 0.41% |
2023-05-30 | Fidelity Total Market Index Fund | 56.27K | 18.80K | 0.10% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Market Fund | 52.20K | 17.02K | 0.10% |
-
-
-
Buy $TYME. Hear me out. New ceo and 100m share offering. Same week they patent covid oral cure. cup and handle is being formed. Reason for red day. Past 3.18 this will blast multiples. Please do your dd and thank me later.
P.s. the new ceo of TYME is the one the ceo that sold the current cure to Pfizer. So........ -
Buy $TYME. Hear me out. New ceo and 100m share offering. Same week they patent covid oral cure. cup and handle is being formed. Reason for red day. Past 3.18 this will blast multiples. Please do your dad and thank me later.
P.s. the new ceo of TYME is the one the ceo that sold the current cure to Pfizer. So........ -
-
-
-
-
-
-
-
-
-
-
-
-
-
$ZYNE Great time to close and reopen at dip around $4.40 when the MACD shows signs. Short interest is too high. Fist wall to break is $6.50 and it’s slowing momentum. Not reaching above 7s quite yet.
-
Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today?
investorplace.com • -
Zynerba Pharma stock rockets on premium priced Harmony deal
proactiveinvestors.com • -
Zynerba ends 3Q with robust $55.9M cash runway to advance its Zygel CBD Gel for Fragile X Syndrome
proactiveinvestors.com • -
Zynerba Pharmaceuticals receives new US patent for its cannabidiol formulated gel Zygel
proactiveinvestors.com • -
Weed Stocks This Week: Major Earnings Blitz
schaeffersresearch.com • -
Zynerba Pharmaceuticals reports Q2 results and provides operational update
proactiveinvestors.com • -
3 Penny Stocks, Are They Worth Buying Right Now?
pennystocks.com • -
Zynerba Pharmaceuticals to Present at the Needham Virtual Healthcare Conference
globenewswire.com • -
Cannabis Sector Kicks Off March With a Blast of Q4 Earnings
schaeffersresearch.com • -
Canaccord Genuity calls Zynerba "undervalued," reiterates Buy rating after positive 4Q results
proactiveinvestors.com • -
Zynerba Pharmaceuticals Names New CLO & Corporate Secretary
benzinga.com • -
Zynerba Pharmaceuticals further boosts patent portfolio for its Zygel CBD gel
proactiveinvestors.com • -
Zynerba Pharmaceuticals ends 3Q with $75.6 million in the bank
proactiveinvestors.com • -
Top Penny Stocks To Buy The Dip According To Analysts In September
pennystocks.com • -
Zynerba initiates RECONNECT Phase 3 trial of Zygel for Fragile X syndrome
proactiveinvestors.com • -
A Week's Worth of Actionable Cannabis Stock News
schaeffersresearch.com • -
Zynerba Pharmaceuticals flush with $85.8M in 2Q to fund pivotal trials of its flagship Zygel CBD gel
proactiveinvestors.com • -
Why Weed Penny Stocks Are Up Today & 3 to Watch as Tilray Skyrockets
pennystocks.com • -
Zynerba Pharmaceuticals showcases Zygel study poster at annual SLEEP meeting
proactiveinvestors.com • -
Smoked! How the Hottest Cannabis Stocks Fared This Week
schaeffersresearch.com • -
Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting
globenewswire.com • -
Here Are the Cannabis Stocks That Caught Fire This Week
schaeffersresearch.com • -
These Reddit Penny Stocks Are Soaring Today, Are They Worth Buying?
pennystocks.com • -
Zynerba presents two posters on Zygel at the Society of Biological Psychiatry 2021 Virtual Meeting
proactiveinvestors.com • -
Zynerba: Repeated Trial Failures, Some Post Hoc Success
seekingalpha.com • -
8 Cannabis Stocks on Fire After Corporate Moves
schaeffersresearch.com • -
Zynerba Pharmaceuticals to Participate in the 33rd Annual ROTH Conference
globenewswire.com • -
ZYNE Stock: Why Zynerba Pharmaceutical Shares Are Soaring Today
investorplace.com • -
ZYNE Stock Price Increases Over 20%: Why It Happened
pulse2.com • -
Zynerba Pharmaceuticals to Present at Two January Virtual Investor Conferences
globenewswire.com • -
Shuman, Glenn & Stecker Investigates Zynerba Pharmaceuticals, Inc.
businesswire.com • -
11 Cannabis Stocks Making Moves While Riding the 'Green Wave'
schaeffersresearch.com • -
Zynerba Zygel Remains A Huge Part Of The Company's Pipeline Despite Setback
seekingalpha.com •